Travel-associated hepatitis A in Europe, 2009 to 2015
Beauté, J., Westrell, T., Schmid, D., Müller, L., Epstein, J., Kontio, M., Couturier, E., Faber, M., Mellou, K., Borg, M.-L., Friesema, I., Vold, L., Severi, E.
Hepatitis B/C in the countries of the EU/EEA: A systematic review of the prevalence among at-risk groups
Falla, A.M., Hofstraat, S.H.I., Duffell, E., Hahné, S.J.M., Tavoschi, L., Veldhuijzen, I.K.
Impact of hepatitis B vaccination on acute hepatitis B epidemiology in European Union/European Economic Area countries, 2006 to 2014
Miglietta, A., Quinten, C., Lopalco, P.L., Duffell, E.
Estimating the scale of chronic hepatitis B virus infection among migrants in EU/EEA countries
Ahmad, A.A., Falla, A.M., Duffell, E., Noori, T., Bechini, A., Reintjes, R., Veldhuijzen, I.K.
How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015
Jorgensen, P., Mereckiene, J., Cotter, S., Johansen, K., Tsolova, S., Brown, C.
PRECEPT: An evidence assessment framework for infectious disease epidemiology, prevention and control
Harder, T., Takla, A., Eckmanns, T., Ellis, S., Forland, F., James, R., Meerpohl, J.J., Morgan, A., Rehfuess, E., Schünemann, H., Zuiderent-Jerak, T., De Carvalho Gomes, H., Wichmann, O.
Prevention and assessment of infectious diseases among children and adult migrants arriving to the European Union/European Economic Association: A protocol for a suite of systematic reviews for public health and health systems
Pottie, K., Mayhew, A.D., Morton, R.L., Greenaway, C., Akl, E.A., Rahman, P., Zenner, D., Pareek, M., Tugwell, P., Welch, V., Meerpohl, J., Alonso-Coello, P., Hui, C., Biggs, B.-A., Requena-Méndez, A., Agbata, E., Noori, T., Schünemann, H.J.
ECDC Vaccine Scheduler
The Vaccine Scheduler is an interactive tool that shows vaccination schedules for individual EU/EEA countries and specific age groups. With this tool comparisons can be made for vaccination schedules between two countries or by disease for all or a selection of countries.
- Hepatitis A
- Hepatitis B
- Human papillomavirus infection
- Influenza in humans, seasonal
- Invasive Haemophilus influenzae disease
- Meningococcal disease
- Pneumococcal disease
- Prevention and control
- Rotavirus infection
- Tick-borne diseases
Hepatitis A Seroprevalence in a population of immigrants at a French vaccination centreArchived
The authors retrospectively analyzed hepatitis A virus (HAV) seroprevalence in travellers who had been born and lived at least 1 year in a developing country, wanted to travel to a hepatitis A endemic area, and consulted at the vaccination centre of the Institut Pasteur of Paris between September 1, 2008 and February 28, 2010. HAV seroprevalence was 82.4 % for a population of 646 immigrants for whom data were available